Your browser doesn't support javascript.
loading
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?
Roth, Gael S; Neuzillet, Cindy; Sarabi, Matthieu; Edeline, Julien; Malka, David; Lièvre, Astrid.
Afiliação
  • Roth GS; Univ. Grenoble Alpes / Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes / Institute for Advanced Biosciences, CNRS UMR 5309-INSERM U1209, Grenoble, France. Electronic address: groth@chu-grenoble.fr.
  • Neuzillet C; Institut Curie, Versailles Saint-Quentin University - Paris Saclay University, Saint-Cloud, France.
  • Sarabi M; Medical Oncology Department, Centre Léon Bérard, 28 Rue Laennec, Lyon 69008, France; Tumor Escape, Resistance and Immunity Department, Centre de Recherche en Cancérologie de Lyon, INSERM 1052, CNRS 5286, Lyon, France.
  • Edeline J; Medical Oncology, Centre Eugene Marquis, Rennes, France.
  • Malka D; Medical Oncology, Institut Mutualiste Montsouris, Paris, France.
  • Lièvre A; Department of Gastroenterology, Rennes University Hospital, University of Rennes 1, INSERM Unité 1242, Rennes, France.
Eur J Cancer ; 179: 1-14, 2023 01.
Article em En | MEDLINE | ID: mdl-36463640
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Colangiocarcinoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article